Jitendra Swarup, MD
Ophthalmology · Elizabeth City, NCNPI 1467490854
Payments from drug & device makers
Across 409 payments — averaging $1102.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$252K
- AbbVie$153K
- Johnson & Johnson Surgical Vision, Inc.$32K
- Alcon Research LLC$10K
- Alcon$2K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$918
- plus $2K from 18 others
Across 1 payment — averaging $138.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glaukos Corporation$139
What the payments were for
- Food & beverage$4,887100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 101 | $251,503 |
| AbbVie(2 entities) | 99 | $153,132 |
| Johnson & Johnson Surgical Vision, Inc. | 11 | $32,185 |
| Alcon Research LLC | 15 | $9,934 |
| Alcon | 56 | $1,597 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 48 | $918 |
| Ocular Therapeutix, Inc. | 25 | $503 |
| Harrow Eye, LLC | 2 | $283 |
| Sight Sciences, Inc. | 2 | $141 |
| Biotissue Holdings Inc. | 15 | $138 |
| Kala Pharmaceuticals, Inc. | 4 | $137 |
| Sun Pharmaceutical Industries Inc. | 7 | $119 |
| Lensar, Inc. | 3 | $83 |
| Mallinckrodt Hospital Products Inc. | 5 | $77 |
| Omeros Corporation | 4 | $70 |
| Eyevance Pharmaceuticals LLC | 3 | $44 |
| Shire North American Group Inc | 2 | $28 |
| Tarsus Pharmaceuticals, Inc. | 1 | $27 |
| Rxsight Inc | 1 | $22 |
| Merz Pharmaceuticals, LLC | 1 | $20 |
| Akorn, Inc. | 1 | $17 |
| Bausch & Lomb Americas Inc. | 1 | $17 |
| Rayner Intraocular Lenses Limited | 1 | $16 |
| Aerie Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iDoseTR$253
- Clareon$131
- OMNI(R) SURGICAL SYSTEM (US)$124
- AcrySof IQ PanOptix$119
- Unity$117
How this compares
$451,020 in reported general payments places this provider in the 95th percentile of 588 ophthalmology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 264 | $14,891 |
| Ketorolac Tromethamine | 290 | $9,524 |
| Ciprofloxacin Hcl | 248 | $3,004 |
| ErythromycinErythromycin Base | 32 | $319 |
| Latanoprost | 32 | $285 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 12 | $192 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 17 | $178 |
| Tobramycin | 13 | $78 |
| Azithromycin | 22 | $45 |
| Diazepam | 22 | $11 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Elizabeth City
- Glenn JaffeDurham$38.5M
- Lejla VajzovicDurham$7.5M
- Andrew AntoszykCharlotte$4M
- Majda HadziahmetovicDurham$2.4M
- Preeya GuptaRaleigh$2M
- Thomas WilliamsHickory$1.8M
- James HarrisHickory$1.4M
- Rajiv ShahWinston Salem$1.3M
- Patrick KeltyHickory$1.1M
- Julie WoodwardDurham$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.